The UCSF Helen Diller Family Comprehensive Cancer Center brings experts from across cancer specialties within UCSF’s network and beyond to revolutionize how cancer is treated. UCSF Parker Institute investigators continue building on the university’s deep scientific expertise to advance research in T-cell therapies, CRISPR technology, the biology of the immune microenvironment and precision treatments. Lewis Lanier, PhD | Director Lawrence Fong, MD | Co-Director All Investigators Related Press Release PICI, JDRF and Helmsley Trust Form Research Initiative Announcement PICI Young Investigator Retreat 2019 Announcement, Press Release Funding the Future of Cancer Research Announcement, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial Partner Highlight Connecting Patients with Innovative Immunotherapies Our Impact, Partner Highlight All the Right Ingredients: The Founders of ArsenalBio Partner Highlight, Press Release NanoString and PICI Partner to Optimize Cell Therapies